SIGA Technologies, Inc. (NASDAQ:SIGA) Shares Acquired by Bailard Inc.

Bailard Inc. boosted its position in SIGA Technologies, Inc. (NASDAQ:SIGAFree Report) by 31.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 18,800 shares of the company’s stock after purchasing an additional 4,500 shares during the quarter. Bailard Inc.’s holdings in SIGA Technologies were worth $113,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in SIGA. Larson Financial Group LLC bought a new stake in shares of SIGA Technologies in the 3rd quarter worth $30,000. EP Wealth Advisors LLC bought a new stake in SIGA Technologies in the third quarter worth about $82,000. XTX Topco Ltd acquired a new stake in SIGA Technologies in the 3rd quarter valued at about $85,000. Intech Investment Management LLC bought a new position in shares of SIGA Technologies during the 3rd quarter valued at about $120,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in shares of SIGA Technologies by 30.0% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 19,902 shares of the company’s stock worth $120,000 after purchasing an additional 4,597 shares during the last quarter. 55.40% of the stock is currently owned by institutional investors and hedge funds.

SIGA Technologies Price Performance

NASDAQ SIGA opened at $5.47 on Thursday. The company has a market capitalization of $390.59 million, a P/E ratio of 4.56 and a beta of 0.98. SIGA Technologies, Inc. has a 12 month low of $4.75 and a 12 month high of $12.83. The company’s 50 day simple moving average is $6.03 and its 200 day simple moving average is $6.83.

SIGA Technologies Company Profile

(Free Report)

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Featured Stories

Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGAFree Report).

Institutional Ownership by Quarter for SIGA Technologies (NASDAQ:SIGA)

Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.